- Home
- EM vs VNDA Comparison
EM vs VNDA Comparison
Compare EM & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- VNDA
- Stock Information
- Founded
- EM 2017
- VNDA 2002
- Country
- EM China
- VNDA United States
- Employees
- EM N/A
- VNDA N/A
- Industry
- EM Other Consumer Services
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- EM Consumer Discretionary
- VNDA Health Care
- Exchange
- EM Nasdaq
- VNDA Nasdaq
- Market Cap
- EM 286.5M
- VNDA 286.4M
- IPO Year
- EM 2021
- VNDA 2006
- Fundamental
- Price
- EM $1.15
- VNDA $4.74
- Analyst Decision
- EM Hold
- VNDA Strong Buy
- Analyst Count
- EM 1
- VNDA 3
- Target Price
- EM $1.25
- VNDA $15.33
- AVG Volume (30 Days)
- EM 124.6K
- VNDA 474.8K
- Earning Date
- EM 08-21-2025
- VNDA 07-31-2025
- Dividend Yield
- EM N/A
- VNDA N/A
- EPS Growth
- EM N/A
- VNDA N/A
- EPS
- EM N/A
- VNDA N/A
- Revenue
- EM $259,541,587.00
- VNDA $201,351,000.00
- Revenue This Year
- EM $3.30
- VNDA $16.86
- Revenue Next Year
- EM $5.26
- VNDA $39.78
- P/E Ratio
- EM N/A
- VNDA N/A
- Revenue Growth
- EM N/A
- VNDA 13.37
- 52 Week Low
- EM $0.50
- VNDA $3.81
- 52 Week High
- EM $1.17
- VNDA $6.34
- Technical
- Relative Strength Index (RSI)
- EM 64.31
- VNDA 50.12
- Support Level
- EM $1.10
- VNDA $4.60
- Resistance Level
- EM $1.15
- VNDA $4.95
- Average True Range (ATR)
- EM 0.02
- VNDA 0.19
- MACD
- EM -0.00
- VNDA -0.03
- Stochastic Oscillator
- EM 83.33
- VNDA 26.92
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.